Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.

Cheng KO, Montaño DE, Zelante T, Dietschmann A, Gresnigt MS (2024) Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology. Oxf Open Immunol 5(1), iqae010. (Review)

Abstract

Protective immunity to opportunistic fungal infections consists of tightly regulated innate and adaptive immune responses that clear the infection. Immune responses to infections of the vaginal mucosa by Candida species are, however, an exception. In the case of vulvovaginal candidiasis (VVC), the inflammatory response is associated with symptomatic disease, rather than that it results in pathogen clearance. As such VVC can be considered an inflammatory disease, which is a significant public health problem due to its predominance as a female-specific fungal infection. Particularly, women with recurrent VVC (RVVC) suffer from a significant negative impact on their quality of life and mental health. Knowledge of the inflammatory pathogenesis of (R)VVC may guide more effective diagnostic and therapeutic options to improve the quality of life of women with (R)VVC. Here, we review the immunopathogenesis of (R)VVC describing several elements that induce an inflammatory arson, starting with the activation threshold established by vaginal epithelial cells that prevent unnecessary ignition of inflammatory responses, epithelial and inflammasome-dependent immune responses. These inflammatory responses will drive neutrophil recruitment and dysfunctional neutrophil-mediated inflammation. We also review the, sometimes controversial, findings on the involvement of adaptive and systemic responses. Finally, we provide future perspectives on the potential of some unexplored cytokine axes and discuss whether VVC needs to be subdivided into subgroups to improve diagnosis and treatment.

Leibniz-HKI-Authors

Karen Cheng
Axel Dietschmann
Mark Gresnigt
Dolly Estella Montaño Espinosa

Identifier

doi: 10.1093/oxfimm/iqae010

PMID: 39234208